KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $1.3 billion.

  • Bausch Health Companies' Cash & Equivalents rose 81.92% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 81.92%. This contributed to the annual value of $1.2 billion for FY2024, which is 24.71% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Cash & Equivalents is $1.3 billion, which was down 24.26% from $1.7 billion recorded in Q2 2025.
  • Bausch Health Companies' Cash & Equivalents' 5-year high stood at $1.7 billion during Q2 2025, with a 5-year trough of $486.0 million in Q3 2022.
  • For the 3-year period, Bausch Health Companies' Cash & Equivalents averaged around $927.4 million, with its median value being $760.0 million (2023).
  • In the last 5 years, Bausch Health Companies' Cash & Equivalents crashed by 58.53% in 2023 and then spiked by 190.25% in 2025.
  • Bausch Health Companies' Cash & Equivalents (Quarterly) stood at $582.0 million in 2021, then decreased by 3.09% to $564.0 million in 2022, then surged by 67.91% to $947.0 million in 2023, then grew by 24.71% to $1.2 billion in 2024, then skyrocketed by 81.92% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.1 billion during Q1 2025.